Agency Forms Undergoing Paperwork Reduction Act Review, 79591-79592 [2015-32139]
Download as PDF
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
79591
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
comments should be received within 30
days of this notice.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32014 Filed 12–21–15; 8:45 am]
[FR Doc. 2015–32018 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
Proposed Project
CDC Work@Health® Program: Phase 2
Training and Technical Assistance
Evaluation (OMB No. 0920–1006, exp.
date 1/31/2016)—Revision—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
[30Day–16–1006]
mstockstill on DSK4VPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity (FOA) CK16–004,
Epicenters for the Prevention of
Healthcare-Associated Infections,
Antimicrobial Resistance, and Adverse
Events.
Time and Date: 10:00 a.m.–5:00 p.m.,
March 2–3, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Epicenters for the Prevention of
Healthcare-Associated Infections,
Antimicrobial Resistance, and Adverse
Events’’, FOA CK16–004.
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:21 Dec 21, 2015
Jkt 238001
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is continuing to make
available the Work@Health® Program, a
comprehensive worksite health
promotion training program, to support
employers’ efforts to create healthy
work environments and provide
employees with opportunities to make
healthy lifestyle choices. The
Work@Health® Program will train and
support small, mid-size, and large
employers with three primary goals: (1)
Increase understanding of the training
needs of employers and the best way to
deliver skill-based training to them; (2)
Increase employers’ level of knowledge
and awareness of worksite health
program concepts and principles; and 3)
Increase the number of science-based
worksite health programs, policies, and
practices in place in participating
employers’ worksites resulting in
opportunities for employees to
participate in them.
CDC is requesting OMB approval to
continue Phase 2 information collection
with new cohorts of respondents in
2016–2019. Phase 2 procedures were
informed by a needs assessment and
pilot test that were conducted in fall
2013 (‘‘CDC Work@Health® Program:
Phase 1,’’ OMB No. 0920–0989, exp. 9/
30/2014) as well as first year results.
CDC will offer training in four models
(formats): (1) A ‘‘Hands-on’’ instructorled workshop model (T1), (2) a selfpaced ’’Online’’ model (T2), (3) a
combination or ‘‘Blended’’ model (T3),
and (4) a ‘‘Train-the-Trainer’’ model
(T4) designed to prepare qualified
individuals to train employers through
the Hands-on, Online, or Blended
models.
To evaluate the training, information
will be collected from approximately
480 employers and approximately 120
individuals who are interested in
becoming trained/certified instructors
for the Work@Health® Program. In
addition, information will be collected
from approximately 600 participant who
receive training delieverd by the
trained/certified instructors.
Respondents will include employers/
employees, trainees who participate in
E:\FR\FM\22DEN1.SGM
22DEN1
79592
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
the four training models, and training
and technical assistance instructors,
coaches and subject matter experts.
CDC will use the information
collected to evaluate the effectiveness of
the Work@Health® Program in terms of
(1) increasing employer’s knowledge
and awareness of worksite health
concepts, principles, and resources, and
(2) increasing the number of sciencebased worksite health programs,
policies and practices in place at
participating employers’ worksites. The
information will also be used to
continue to identify and improve the
best way(s) to deliver skill-based
training and technical support to
employers in the area of worksite
health.
OMB approval is requested for three
years. Participation in Work@Health® is
voluntary and there are no costs to
participants other than their time. The
total estimated annualized burden hours
are 1,047.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Form name
Interested Employer ................
Employers Participating in
Work@Health.
Employer Application Form ....................................................
CDC Worksite Health Scorecard ...........................................
Organizational Assessment ....................................................
Employer Follow-up Survey ...................................................
Case Study Interviews with Senior Leadership .....................
Case Study Interviews with Employees .................................
Trainee KAB Survey ...............................................................
Trainee Reaction Survey—Hands-On Model .........................
Trainee Reaction Survey—Online Model ...............................
Trainee Reaction Survey—Blended Model ............................
Trainee Technical Assistance Survey ....................................
Case Study Interviews with Selected Trainees .....................
Trainee Focus Group Discussion Guide ................................
Train-the-Trainer Application Form ........................................
400
320
320
160
2
4
640
100
120
100
640
10
7
80
1
1
1
1
1
1
1
1
1
1
1
1
1
1
20/60
0.5
15/60
15/60
1
1
20/60
15/60
15/60
15/60
15/60
1
1.5
0.5
Train-the-Trainer Participant Survey ......................................
Trainee Reaction Survey—Train-the-Trainer Model ..............
Train-the-Trainer Trainee Technical Assistance Survey ........
Wave 2 Trainee Reaction Survey ..........................................
80
40
80
200
1
1
1
1
20/60
15/60
15/60
15/60
Instructor/Coach Group Discussion Guide .............................
7
1
0.5
Trainees Participating in the
Work@Health Program
(Hands-on, Online, Blended
models).
Interested Train-the-Trainer
Participants.
Trainees Participating in the
Work@Health Program
(Train-the-Trainer model).
Trainees participating in the
Work@Health Program
Wave 2.
Work@Health Instructors/
Coaches.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–32139 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) DP 16–001, Pregnancy Risk
Assessment Monitoring System
(PRAMS).
VerDate Sep<11>2014
17:21 Dec 21, 2015
Jkt 238001
Number of
respondents
Average
burden per
response
(in hrs.)
Type of
respondent
Time and Date: 11:00 a.m.–6:00 p.m.,
EST, Panel C, February 3, 2016 (Closed)
Place: Teleconference
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DP16–001, Panel C, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32017 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 9:30 a.m.–4:00 p.m. EST,
January 28, 2016; 9:30 a.m.–3:00 p.m. EST,
January 29, 2016.
E:\FR\FM\22DEN1.SGM
22DEN1
Agencies
[Federal Register Volume 80, Number 245 (Tuesday, December 22, 2015)]
[Notices]
[Pages 79591-79592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32139]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-1006]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
CDC Work@Health[supreg] Program: Phase 2 Training and Technical
Assistance Evaluation (OMB No. 0920-1006, exp. date 1/31/2016)--
Revision--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) is continuing
to make available the Work@Health[supreg] Program, a comprehensive
worksite health promotion training program, to support employers'
efforts to create healthy work environments and provide employees with
opportunities to make healthy lifestyle choices. The
Work@Health[supreg] Program will train and support small, mid-size, and
large employers with three primary goals: (1) Increase understanding of
the training needs of employers and the best way to deliver skill-based
training to them; (2) Increase employers' level of knowledge and
awareness of worksite health program concepts and principles; and 3)
Increase the number of science-based worksite health programs,
policies, and practices in place in participating employers' worksites
resulting in opportunities for employees to participate in them.
CDC is requesting OMB approval to continue Phase 2 information
collection with new cohorts of respondents in 2016-2019. Phase 2
procedures were informed by a needs assessment and pilot test that were
conducted in fall 2013 (``CDC Work@Health[supreg] Program: Phase 1,''
OMB No. 0920-0989, exp. 9/30/2014) as well as first year results. CDC
will offer training in four models (formats): (1) A ``Hands-on''
instructor-led workshop model (T1), (2) a self-paced ''Online'' model
(T2), (3) a combination or ``Blended'' model (T3), and (4) a ``Train-
the-Trainer'' model (T4) designed to prepare qualified individuals to
train employers through the Hands-on, Online, or Blended models.
To evaluate the training, information will be collected from
approximately 480 employers and approximately 120 individuals who are
interested in becoming trained/certified instructors for the
Work@Health[supreg] Program. In addition, information will be collected
from approximately 600 participant who receive training delieverd by
the trained/certified instructors. Respondents will include employers/
employees, trainees who participate in
[[Page 79592]]
the four training models, and training and technical assistance
instructors, coaches and subject matter experts.
CDC will use the information collected to evaluate the
effectiveness of the Work@Health[supreg] Program in terms of (1)
increasing employer's knowledge and awareness of worksite health
concepts, principles, and resources, and (2) increasing the number of
science-based worksite health programs, policies and practices in place
at participating employers' worksites. The information will also be
used to continue to identify and improve the best way(s) to deliver
skill-based training and technical support to employers in the area of
worksite health.
OMB approval is requested for three years. Participation in
Work@Health[supreg] is voluntary and there are no costs to participants
other than their time. The total estimated annualized burden hours are
1,047.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Interested Employer................ Employer Application Form.. 400 1 20/60
Employers Participating in CDC Worksite Health 320 1 0.5
Work@Health. Scorecard. 320 1 15/60
Organizational Assessment..
Employer Follow-up Survey.. 160 1 15/60
Case Study Interviews with 2 1 1
Senior Leadership.
Case Study Interviews with 4 1 1
Employees.
Trainees Participating in the Trainee KAB Survey......... 640 1 20/60
Work@Health Program (Hands-on, Trainee Reaction Survey-- 100 1 15/60
Online, Blended models). Hands-On Model. 120 1 15/60
Trainee Reaction Survey-- 100 1 15/60
Online Model.
Trainee Reaction Survey--
Blended Model.
Trainee Technical 640 1 15/60
Assistance Survey.
Case Study Interviews with 10 1 1
Selected Trainees.
Trainee Focus Group 7 1 1.5
Discussion Guide.
Interested Train-the-Trainer Train-the-Trainer 80 1 0.5
Participants. Application Form.
Trainees Participating in the Train-the-Trainer 80 1 20/60
Work@Health Program (Train-the- Participant Survey. 40 1 15/60
Trainer model). Trainee Reaction Survey-- 80 1 15/60
Train-the-Trainer Model.
Train-the-Trainer Trainee
Technical Assistance
Survey.
Trainees participating in the Wave 2 Trainee Reaction 200 1 15/60
Work@Health Program Wave 2. Survey.
Work@Health Instructors/Coaches.... Instructor/Coach Group 7 1 0.5
Discussion Guide.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-32139 Filed 12-21-15; 8:45 am]
BILLING CODE 4163-18-P